These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 33429364)
21. Identification and verification on prognostic index of glioblastoma immune-related lncRNAs. Zheng G; Jiang Q; Jiang C; Zhu X; Wang Y Adv Clin Exp Med; 2024 Aug; 33(8):843-856. PubMed ID: 38376452 [TBL] [Abstract][Full Text] [Related]
22. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas. Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J Front Immunol; 2020; 11():585034. PubMed ID: 33193404 [TBL] [Abstract][Full Text] [Related]
23. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme. Wang K; Lu Y; Liu Z; Diao M; Yang L Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681 [TBL] [Abstract][Full Text] [Related]
24. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses. Ye S; Yang B; Zhang T; Wei W; Li Z; Chen J; Li X Cells; 2022 Sep; 11(19):. PubMed ID: 36230961 [TBL] [Abstract][Full Text] [Related]
25. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma. Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G Front Immunol; 2021; 12():706936. PubMed ID: 34899682 [TBL] [Abstract][Full Text] [Related]
26. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients. Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757 [TBL] [Abstract][Full Text] [Related]
27. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
28. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma. Xiao Y; Wang Z; Zhao M; Ji W; Xiang C; Li T; Wang R; Yang K; Qian C; Tang X; Xiao H; Zou Y; Liu H Math Biosci Eng; 2022 Jun; 19(9):9481-9504. PubMed ID: 35942769 [TBL] [Abstract][Full Text] [Related]
29. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme. Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482 [TBL] [Abstract][Full Text] [Related]
30. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma. Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165 [TBL] [Abstract][Full Text] [Related]
31. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers]. Liu J; Xu K; Ma L; Wang Y Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410 [TBL] [Abstract][Full Text] [Related]
32. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U Front Immunol; 2020; 11():1402. PubMed ID: 32765498 [TBL] [Abstract][Full Text] [Related]
33. A new prognostic model for glioblastoma multiforme based on coagulation-related genes. Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372 [TBL] [Abstract][Full Text] [Related]
34. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Zhao WJ; Ou GY; Lin WW Front Immunol; 2021; 12():682415. PubMed ID: 34054873 [TBL] [Abstract][Full Text] [Related]
36. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D Front Immunol; 2022; 13():773264. PubMed ID: 35185876 [TBL] [Abstract][Full Text] [Related]
37. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma. Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984 [TBL] [Abstract][Full Text] [Related]
38. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma. Prasad B; Tian Y; Li X Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483 [TBL] [Abstract][Full Text] [Related]
39. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
40. Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis. Wen YD; Zhu XS; Li DJ; Zhao Q; Cheng Q; Peng Y Sci Rep; 2021 Aug; 11(1):17170. PubMed ID: 34446747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]